Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells.
Open Access
- 1 May 1989
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 83 (5) , 1570-1579
- https://doi.org/10.1172/JCI114054
Abstract
Recombinant tumor necrosis factor (rTNF) and rIFN-gamma induce in the human leukemia cell lines HL-60, ML3, and U937 the accumulation of transcripts of the X chromosome-linked chronic granulomatous disease (X-CGD) gene, encoding the 91-kD heavy chain of cytochrome b-245, a component of the NADPH oxidase of phagocytic cells. The gene is induced within 6 h by either cytokine, and its accumulation is observed upon induction with rIFN-gamma up to 5 d. The combined effect of the two cytokines is more than additive. rIFN-gamma also induces accumulation of X-CGD mRNA in immature myeloid cells from peripheral blood of chronic myeloid leukemia (CML) patients, whereas rTNF has almost no effect. The cells from CML patients constitutively express TNF mRNA, suggesting that endogenously produced TNF may play a role in the effect of rIFN-gamma on these cells. rTNF induces X-CGD gene expression in the myeloid cell lines acting, at least in part, at the transcriptional level, as shown in nuclear run-on experiments. The gene encoding the 22-kD light chain of cytochrome b-245 is constitutively expressed in the human myeloid cell lines and the accumulation of its transcripts is affected by neither rTNF nor rIFN-gamma, rTNF and rIFN-gamma synergistically to induce the cell lines to express the cytochrome b-245 heterodimer (as evaluated by its visible spectrum), and to produce NADPH oxidase activity and H2O2 upon stimulation with phorbol diesters.This publication has 54 references indexed in Scilit:
- Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon GammaNew England Journal of Medicine, 1988
- Specific activation by concanavalin A of the superoxide anion generation capacity during U937 differentiationBiochemical and Biophysical Research Communications, 1988
- The quaternary structure of the plasma membrane b-type cytochrome of human granulocytesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1988
- Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.Journal of Clinical Investigation, 1987
- Cell-free activation of phagocyte NADPH-oxidase: Tissue and differentiation-specific expression of cytosolic cofactor activityBiochemical and Biophysical Research Communications, 1987
- The O2−-forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and functionBiochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics, 1986
- Gamma interferon is able to enhance the oxidative metabolism of human neutrophilsBiochemical and Biophysical Research Communications, 1986
- Activation by gamma interferon of human macrophage capability to produce toxic oxygen molecules is accompanied by decreased km of the superoxide-generating NADPH oxidaseBiochemical and Biophysical Research Communications, 1985
- Partial purification of the superoxide-generating system of macrophages. Possible association of the NADPH oxidase activity with a low-potential (−247 mV) cytochrome bBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1985
- Development of cytochrome b and an active oxidase system in association with maturation of a human promyelocytic (HL-60) cell lineThe Journal of cell biology, 1982